Glenmark FabiFlu Tablets
Glenmark FabiFlu Tablets
| Packaging Size | 34 Tablets |
| Brand | FabiFlu |
| Composition | Favipiravir |
| Manufacturer | Glenmark Pharmaceuticals |
| Treatment | COVID-19 and Viral Infections |
| Form | Tablet |
Glenmark Pharmaceuticals has become the first Indian company to commercially launch an antiviral drug for the treatment of mild to moderate COVID-19 patients, following approval from the Drug Controller General of India (DCGI).
